Absolute Risk of Death is Lower in Left Ventricular Assist Device Patients with Good Anticoagulation Control

Autor: N. van Rein, Laurens F. Tops, E. Janssen, F. J. M. Van Der Meer, Saskia L.M.A. Beeres, J.W. Jukema

Publikováno v: The Journal of Heart and Lung Transplantation. 40:S387

Purpose Patients with continuous-flow (CF) left ventricular assist devices (LVADs) as destination therapy (DT) require anticoagulation with vitamin K antagonists (VKAs). A time in therapeutic range (TTR) of international normalized ratio above 60% is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::329a42be92a855d2bf8859bd86522030
https://doi.org/10.1016/j.healun.2021.01.1087

Increased risk of major bleeding after a minor bleed during treatment with vitamin K antagonists is determined by fixed common risk factors

Autor: I. P. van Vliet, N. van Rein, Willem M. Lijfering, Pieter H. Reitsma, Suzanne C. Cannegieter, F. J. M. Van Der Meer, S. le Cessie

Publikováno v: Journal of Thrombosis and Haemostasis, 14(5), 948-952

UNLABELLED Essentials Minor bleeding is associated with subsequent major bleeding in patients treated with vitamin K antagonists. This study confirms that patients with minor bleeds have a 2.5-fold increased risk of major bleeds. A case-crossover ana

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190e4eb7212efd1fb296afea07091f7e
https://doi.org/10.1111/jth.13306

Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear interpolation: Reply

Autor: F. J. M. Van Der Meer, Marieke J. H. A. Kruip, Joseph S. Biedermann, Henk J. Adriaansen, A. M. H. P. Van Den Besselaar, F. W. G. Leebeek

Publikováno v: Thrombosis and Haemostasis, 117(4), 820-821. Georg Thieme Verlag
Thrombosis and Haemostasis, 117(4), 820-821

Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear interpolation: Reply

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cced987503aedebef709696b066e904
https://hdl.handle.net/1887/114563

Vitamin K1 in oral solution or tablets: a crossover trial and two randomized controlled trials to compare effects

Autor: F. J. M. Van Der Meer, J. J. E. Groeneveld, S. le Cessie, N. van Rein, Willem M. Lijfering, F. A. L. van der Horst, E. P. A. Gebuis, F. R. Rosendaal

Publikováno v: Journal of Thrombosis and Haemostasis, 12(12), 2017-2023

Summary. Background: Vitamin K1 (VK1) reverses the effects of vitamin K antagonists (VKAs). The literature shows that the bioavailability from solutions might be higher than that from tablets, possibly resulting in different effects. Objectives: To c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a354e6a39567058147978ef144e68f
https://doi.org/10.1111/jth.12753

Diagnostic strategy for the assessment of rheumatoid vasculitis

Autor: F J M van der Meer, F. C. Breedveld, J. M. W. Hazes, E M Paleolog, M. R. Daha, Alexandre E. Voskuyl, A. H. Zwinderman

Publikováno v: Annals of the Rheumatic Diseases, 62, 407-413. BMJ Publishing Group
Annals of the Rheumatic Diseases, 62(5), 407-13. BMJ Publishing Group
Voskuijl, A E, Hazes, JM, Zwinderman, A H, Paleolog, EM, van der Meer, FJ, Daha, MR & Breedveld, F C 2003, ' Diagnostic strategy for the assessment of rheumatoid vasculitis. ', Annals of the Rheumatic Diseases, vol. 62, no. 5, pp. 407-13 . https://doi.org/10.1136/ard.62.5.407
Annals of the rheumatic diseases, 62(5), 407-413. BMJ Publishing Group

Objective: To determine the clinical features associated with histologically proven rheumatoid vasculitis (HRV) and the additional diagnostic value of serological markers in an inception cohort of 81 patients with rheumatoid arthritis (RA) suspected

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52e62b5f3cd6ecb3a75c323f3edd1c47
https://doi.org/10.1136/ard.62.5.407